Contrary to popular belief, curing a disease can be more economically valuable than relying on ongoing monthly treatments. Recent findings show that a one-time cure, achieving the same patient outcomes without recurring prescriptions, can offer over twice the financial return. Chief Futurist Brett Winton covers more on The Brainstorm.
|
----------------------------------------...
----------------------------------------...
On today's episode of Bloomberg Business...
Elon Musk plans to merge SpaceX with xAI...
The Metropolitan Police say they are rev...
Nvidia Corp. supports “every developer” ...
----------------------------------------...
"Bloomberg ETF IQ" focuses on the opport...
On the early edition of Balance of Power...
Ross Gerber, co-founder and CEO of Gerbe...
Israel has kept the Rafah crossing betwe...
As anticipation builds as to when and ho...
----------------------------------------...